FL
BIO icon

Fort LP’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fort LP’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-588
Closed -$444K – 271
2021
Q4 		$444K Sell
588
-672
-53% -$503K 0.14% 235
2021
Q3 		$940K Sell
1,260
-662
-34% -$496K 0.31% 156
2021
Q2 		$1.24M Sell
1,922
-719
-27% -$438K 0.36% 159
2021
Q1 		$1.51M Buy
2,641
+350
+15% +$207K 0.42% 158
2020
Q4 		$1.34M Buy
2,291
+1,269
+124% +$723K 0.4% 163
2020
Q3 		$527K Buy
+1,022
New +$518K 0.22% 202
2019
Q4 		– Sell
-362
Closed -$120K – 449
2019
Q3 		$120K Buy
+362
New +$118K 0.02% 325

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return